glp 1 vietnam launches first fund with investment capacity of $1.1 bil Vietnam's Obesity Threat: Hope in

2025 May;46(5):422-436

However, direct comparisons require caution because: Trial lengths differed Dosing protocols differed Patient populations differed Long-term orforglipron data is still developing A 5% to 10% reduction in body weight can still produce clinically meaningful improvements in blood pressure, insulin sensitivity, mobility, and metabolic health

2022 Feb 25;13(1):1057

They may actually find that their new set point is a little thinner, a little more sparse in terms of the number of hair follicles than it was because it's not as resilient, says Garshick

The encouraging news is that in most cases, its temporary and reversible

and was brought to market for individuals living with type 2 diabetes